Scarica l'app Stockscreener
86.53
0.37%
0.32
Dopo l'orario di chiusura:
86.53
Precedente Chiudi:
$86.21
Aprire:
$86.45
Volume 24 ore:
3.43M
Relative Volume:
3.30
Capitalizzazione di mercato:
$10.78B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-22.32
EPS:
-3.876
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
-1.36%
1M Prestazione:
+0.66%
6M Prestazione:
+18.93%
1 anno Prestazione:
+45.36%
Intervallo 1D:
$86.25
$88.90
Intervallo di 1 settimana:
$84.46
$92.94
Portata 52W:
$53.83
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Nome
Vaxcyte Inc
Settore
Industria
Telefono
650-837-0111
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Confronta PCVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
86.53 | 10.78B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-07 | Iniziato | Mizuho | Buy |
| 2023-04-18 | Iniziato | TD Cowen | Outperform |
| 2023-01-03 | Reiterato | Needham | Buy |
| 2022-12-15 | Iniziato | Guggenheim | Buy |
| 2022-11-17 | Iniziato | BTIG Research | Buy |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-06-24 | Ripresa | Jefferies | Buy |
| 2020-07-07 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Iniziato | Needham | Buy |
Mostra tutto
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset - MSN
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ) - Seeking Alpha
The Goldman Sachs Group Begins Coverage on Vaxcyte (NASDAQ:PCVX) - MarketBeat
Vaxcyte stock supported by Goldman Sachs for addressing next-gen vaccine challenges - Investing.com
Vaxcyte's president and CFO sells $710,248 in stock transactions - Investing.com India
Vaxcyte's president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of Stock - MarketBeat
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - EIN News
(PCVX) Investment Report - Stock Traders Daily
Lord Abbett & CO. LLC Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Franklin Resources Inc. Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Geode Capital Management LLC Buys 259,010 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Analysts - MarketBeat
Applied Industrial Technologies (AIT-N) QuotePress Release - The Globe and Mail
Merck & Company (MRK-N) QuotePress Release - The Globe and Mail
Why Wall Street Rates These 2 Russell 2000 Stocks a “Strong Buy” - MSN
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life ScienceSan Carlos Mega Campus (PR Newswire) - Aktiellt
Vaxcyte, Inc. (NASDAQ:PCVX) is Frazier Life Sciences Management L.P.'s 7th Largest Position - MarketBeat
Y Intercept Hong Kong Ltd Increases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Zacks Investment Management Acquires Shares of 13,645 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
State Street Corp Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
What Makes Vaxcyte (PCVX) An Investment Bet? - MSN
Vaxcyte's SVP Mikhail Eydelman sells $457k in stock By Investing.com - Investing.com UK
Stocks With Rising Relative Strength: Vaxcyte - MSN
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Simply Wall St
Pier Capital LLC Reduces Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
(PCVX) Trading Signals - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by RA Capital Management L.P. - MarketBeat
Point72 Asset Management L.P. Takes Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Polar Asset Management Partners Inc. Sells 44,200 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Bank of Montreal Can Invests $3.10 Million in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants - Yahoo! Voices
Parkman Healthcare Partners LLC Trims Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Maven Securities LTD Acquires Shares of 129,700 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Bamco Inc. NY Makes New $3.54 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Vaxcyte CEO Grant Pickering sells $1.39 million in stock By Investing.com - Investing.com Canada
Vaxcyte CEO Grant Pickering sells $1.39 million in stock - Investing.com
Vaxcyte COO Jim Wassil sells $739,884 in stock By Investing.com - Investing.com UK
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants - GlobeNewswire
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal - The Bakersfield Californian
HighVista Strategies LLC Grows Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cinctive Capital Management LP Purchases Shares of 32,494 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
Braidwell LP Sells 510,735 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Fred Alger Management LLC Reduces Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Eventide Asset Management LLC Has $43.82 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaccine maker doubles its space at Bay Area biotech mega-campus - MSN
Acuta Capital Partners LLC Has $15.47 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug - MSN
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vaxcyte Inc Azioni (PCVX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Dec 18 '24 |
Sale |
88.78 |
8,000 |
710,249 |
109,491 |
| Cowan Elvia | SVP, FINANCE |
Dec 16 '24 |
Option Exercise |
25.92 |
7,716 |
199,999 |
19,294 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):